Dermal Fillers

JUVÉDERM® VOLUMA® XC is the first and only FDA-approved filler to instantly add volume to the cheek area — restoring youthful lift and contour to the mid-face. Formulated with Allergan’s advanced Vycross® technology, which combines different molecular weights of hyaluronic acid for a more efficient, tightly cross-linked gel, VOLUMA® XC delivers a firmer, more supportive lift that resists gravity more effectively than softer fillers.

VOLUMA® XC is also FDA-approved for:

* Chin augmentation — adding subtle volume to contour, shape, and define the chin

* Temple hollowing — the first and only HA filler approved to treat moderate to severe temple hollowing, with 90% patient satisfaction and 85% reporting improvement lasting up to 13 months

Results can last up to 2 years with optimal treatment.

JUVÉDERM® VOLLURE® XC is designed to smooth moderate to severe facial wrinkles and folds — particularly the nasolabial folds (parentheses lines) and marionette lines that form around the nose and mouth as skin thins and loses elasticity. Its Vycross® technology allows for a softer, more flexible consistency that moves naturally with facial expression while maintaining correction.

Results last up to 18 months — among the longest-lasting of any filler in this category.

JUVÉDERM® VOLBELLA® XC is formulated with smaller HA molecules for a softer, more subtle result in the delicate areas around the mouth and under the eyes. It is the first and only filler FDA-approved to both augment the lips and soften vertical lip lines, and is also approved for improving infraorbital hollowing (under-eye area).

VOLBELLA® XC is the ideal choice for patients seeking natural-looking lip enhancement — adding subtle fullness without overcorrection. Results last up to 1 year with optimal treatment.

JUVÉDERM® Ultra XC and Ultra Plus XC use Allergan’s HYLACROSS™ technology to create a smooth, homogeneous gel that is ideal for treating moderate to severe facial wrinkles and folds. Ultra XC provides versatile contouring and lip augmentation; Ultra Plus XC is designed for deeper, more severe folds and wrinkles requiring more substantial correction. Both have been shown to last up to 1 year.

BOTOX® and dermal fillers are complementary treatments that address fundamentally different aspects of facial aging. BOTOX® relaxes dynamic wrinkles caused by muscle movement, while fillers address static volume loss and structural changes. Combined, they allow for smoother skin, restored volume, and improved facial balance — often referred to as a “liquid facelift” when performed together as a comprehensive treatment plan.

While dermal fillers provide immediate volume, Sculptra® gradually rebuilds the underlying collagen framework that supports the entire face. Used together, fillers provide the immediate correction while Sculptra® addresses the long-term structural dimension of aging — creating both instant and progressive improvement that is more comprehensive than either treatment alone.

For patients seeking more permanent volume restoration, surgical fat transfer using the patient’s own harvested fat provides lasting, natural architectural results that fillers cannot replicate. Fat transfer and fillers can be used together — fillers for immediate and precise correction, fat transfer for permanent volume in larger areas.

Combining dermal fillers with Morpheus8 RF microneedling or the SkinTite platform addresses volume loss alongside skin tightening and texture improvement — creating a more comprehensive facial rejuvenation result.